These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 33822400
1. Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo. Thulin MH, Määttä J, Linder A, Sterbova S, Ohlsson C, Damber JE, Widmark A, Persson E. Prostate; 2021 Jun; 81(8):452-462. PubMed ID: 33822400 [Abstract] [Full Text] [Related]
2. Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells. Han D, Yu T, Dong N, Wang B, Sun F, Jiang D. J Exp Clin Cancer Res; 2019 Jul 05; 38(1):289. PubMed ID: 31277685 [Abstract] [Full Text] [Related]
3. STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells. Liu Y, Peng X, Li H, Jiao W, Peng X, Shao J, Xu Y, Wang R, Wang W, Kong D. Recent Pat Anticancer Drug Discov; 2021 Jul 05; 16(3):350-362. PubMed ID: 33655847 [Abstract] [Full Text] [Related]
4. Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin. Zhang Y, Jin Z, Zhou H, Ou X, Xu Y, Li H, Liu C, Li B. Cancer Med; 2016 Jun 05; 5(6):1251-8. PubMed ID: 26899963 [Abstract] [Full Text] [Related]
5. Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells. Zuo D, Shogren KL, Zang J, Jewison DE, Waletzki BE, Miller AL, Okuno SH, Cai Z, Yaszemski MJ, Maran A. J Exp Clin Cancer Res; 2018 Oct 04; 37(1):244. PubMed ID: 30286779 [Abstract] [Full Text] [Related]
6. Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor. Hubbard JM, Grothey A. Drugs; 2017 Jul 04; 77(10):1091-1103. PubMed ID: 28573435 [Abstract] [Full Text] [Related]
7. Napabucasin, a novel inhibitor of STAT3, inhibits growth and synergises with doxorubicin in diffuse large B-cell lymphoma. Li X, Wei Y, Wei X. Cancer Lett; 2020 Oct 28; 491():146-161. PubMed ID: 32798587 [Abstract] [Full Text] [Related]
8. STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice. Bitsch R, Kurzay A, Özbay Kurt F, De La Torre C, Lasser S, Lepper A, Siebenmorgen A, Müller V, Altevogt P, Utikal J, Umansky V. J Immunother Cancer; 2022 Mar 28; 10(3):. PubMed ID: 35301236 [Abstract] [Full Text] [Related]
9. A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3). Li C, Chen C, An Q, Yang T, Sang Z, Yang Y, Ju Y, Tong A, Luo Y. Eur J Med Chem; 2019 Jan 15; 162():543-554. PubMed ID: 30472602 [Abstract] [Full Text] [Related]
10. Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells. Löcken H, Clamor C, Müller K. J Nat Prod; 2018 Jul 27; 81(7):1636-1644. PubMed ID: 30003778 [Abstract] [Full Text] [Related]
11. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer. Han Z, Wang X, Ma L, Chen L, Xiao M, Huang L, Cao Y, Bai J, Ma D, Zhou J, Hong Z. Oncotarget; 2014 Sep 30; 5(18):8416-28. PubMed ID: 25261365 [Abstract] [Full Text] [Related]
14. Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies. Hagberg Thulin M, Jennbacken K, Damber JE, Welén K. Clin Exp Metastasis; 2014 Mar 30; 31(3):269-83. PubMed ID: 24292404 [Abstract] [Full Text] [Related]
16. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer. Canesin G, Evans-Axelsson S, Hellsten R, Sterner O, Krzyzanowska A, Andersson T, Bjartell A. Eur Urol; 2016 Mar 30; 69(3):400-4. PubMed ID: 26144873 [Abstract] [Full Text] [Related]
17. STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells. Guha P, Gardell J, Darpolor J, Cunetta M, Lima M, Miller G, Espat NJ, Junghans RP, Katz SC. Oncogene; 2019 Jan 30; 38(4):533-548. PubMed ID: 30158673 [Abstract] [Full Text] [Related]
19. Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo. Shukeir N, Stefanska B, Parashar S, Chik F, Arakelian A, Szyf M, Rabbani SA. Br J Pharmacol; 2015 Jun 30; 172(11):2769-81. PubMed ID: 25631332 [Abstract] [Full Text] [Related]
20. Thermal Proteome Profiling in Zebrafish Reveals Effects of Napabucasin on Retinoic Acid Metabolism. Leijten NM, Bakker P, Spaink HP, den Hertog J, Lemeer S. Mol Cell Proteomics; 2021 Jun 30; 20():100033. PubMed ID: 33594990 [Abstract] [Full Text] [Related] Page: [Next] [New Search]